Linked Life Data

11528234

Source:http://linkedlifedata.com/resource/pubmed/id/11528234

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-8-30
pubmed:abstractText
Abacavir is a potent, novel 2'-deoxyguanosine analogue reverse transcriptase inhibitor (NRTI) which effectively suppresses HIV-1 replication. To date, there is no pharmacokinetic study in patients with renal impairment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0028-2766
pubmed:author
pubmed:copyrightInfo
Copyright 2001 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
62-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Pharmacokinetics of abacavir in HIV-1-infected patients with impaired renal function.
pubmed:affiliation
Department of Nephrology, Pitié-Salpêtrière Hospital, 47-83 bd de l'Hôpital, F-75013 Paris, France. hassan.izzedine@psl.ap-hop-paris.fr
pubmed:publicationType
Journal Article, Clinical Trial